Glivec Tab 100Mg 60S is a prescribed medication containing the active ingredient imatinib. This medicine is crucial in the treatment of specific types of cancer and leukemia in both adults and children. These conditions include:
- Chronic myeloid leukaemia (CML)
- Acute lymphoblastic leukaemia with Philadelphia chromosome positive (Ph-positive ALL)
- Myelodysplastic / myeloproliferative diseases (MDS/MPD)
- Aggressive systemic mastocytosis (ASM)
Hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL)
The therapeutic mechanism of Glivec centers around targeting and inhibiting the activity of a protein known as BCR-ABL. This protein is present in cells associated with CML and Ph-positive ALL, driving their excessive growth. By thwarting BCR-ABL's activity, Glivec effectively manages the growth of these cells, leading to improved patient conditions.
Manufactured By |
Novartis Pharmaceuticals (Pvt) Ltd |
Product Form |
Tablets |
Generic Category |
Anticancer |
Ingredients |
Imatinib Mesilate |
Pack Size |
60's |
Age |
Adults |
Recommended Dosage |
400 mg for adults with CML and Ph-positive ALL 100 mg for adults with MDS/MPD, ASM, HES, and CEL |
- Glivec (imatinib) is a prescription medication that is used to treat chronic myeloid leukemia (CML), acute lymphoblastic leukemia with Philadelphia chromosome positive (Ph+ ALL), myelodysplastic/myeloproliferative diseases (MDS/MPD), aggressive systemic mastocytosis (ASM), hypereosinophilic syndrome (HES) and or chronic eosinophilic leukaemia (CEL).
- Glivec is taken by mouth once a day. The usual dose is 400 mg for adults with CML and Ph+ ALL, and 100 mg for adults with MDS/MPD, ASM, HES, and CEL. The dose may need to be adjusted depending on the patient's response to treatment.
Glivec Uses
Glivec (imatinib mesylate) is a prescription medication that is used to treat certain types of cancer and leukemia, including:
- Chronic myeloid leukemia (CML)
- Acute lymphoblastic leukemia with Philadelphia chromosome positive (Ph+ ALL)
- Myelodysplastic/myeloproliferative diseases (MDS/MPD)
- Aggressive systemic mastocytosis (ASM)
- Hypereosinophilic syndrome (HES) and or chronic eosinophilic leukaemia (CEL)
The most common side effects of Glivec are:
- Nausea and vomiting
- Diarrhea
- Headache
- Fatigue
- Dizziness
- Rash
- Muscle pain
- Joint pain
- Stomach pain
- Dry skin
- Hair loss
- Liver problems
- Kidney problems
- Bleeding
- Infection
Other side effects of Glivec can include:
- A serious skin reaction called Stevens-Johnson syndrome
- A serious allergic reaction
- Heart problems
- Stroke
- Pancreatitis
- Lung problems
- Eye problems
- Nervous system problems
- Bone marrow problems
- Fertility problems
- Strong CYP3A4 Inhibitors: Medications that inhibit the CYP3A4 enzyme can increase the concentration of Glivec in the body, leading to potential adverse effects. Examples include ketoconazole, itraconazole, clarithromycin, and grapefruit juice.
- Strong CYP3A4 Inducers: Drugs that induce the CYP3A4 enzyme can decrease the concentration of Glivec, reducing its effectiveness. Examples include rifampicin, phenytoin, carbamazepine, and St. John's wort.
- Antacids: Taking antacids or proton pump inhibitors along with Glivec can reduce its absorption, potentially decreasing its efficacy. It's advised to separate the dosages by a few hours.
- Warfarin: Glivec may interact with warfarin, an anticoagulant, potentially altering the blood-thinning effects. Regular monitoring of blood clotting times is recommended.
- Immunosuppressants: Drugs used to suppress the immune system, like cyclosporine, can interact with Glivec and require careful monitoring.
- QT Interval Prolonging Drugs: Certain medications that prolong the QT interval (a heart rhythm parameter) may interact with Glivec and increase the risk of arrhythmias.
- HIV Medications: Some HIV medications can affect the metabolism of Glivec, leading to altered blood levels.
- Other Cancer Treatments: Combining Glivec with other cancer treatments may increase the risk of adverse effects or reduce treatment efficacy.